Table 1 Patient characteristics
Patient NoSexAge (y)Disease duration (y)DYT1 gene statusSite of onsetWorst affected areasBFM score pre-op/6 mo (0–120)MedicationsDBS parameters
1F189+R handTrunk, R limbs48/1TrihexyphenidylR: 4,5-, 3.9 v, 60 μs, 130 Hz
L: 0,1-, 3.9 v, 60 μs, 130 Hz
2M2416R handNeck, trunk, R limbs73/15ClonazepamR: 4,5-, 3.9 v, 90 μs, 130 Hz
L: 0,1-, 3.8 v, 90 μs, 130 Hz
3M4737+L legNeck, trunk, L side52/22Diazepam, TetrabenazineR: 4-, 3.5 v, 90 μs, 130 Hz
L: 0,1-, 3.3 v, 60 μs, 130 Hz
4F2312R legTrunk, R leg53/32NoneR: 5-, 4.0 v, 60 μs, 130 Hz
L: 1-, 4.2 v, 60 μs, 130 Hz
5F5236+L armL limbs29/7NoneR: 4-, 3.0 v, 60 μs, 130 Hz
L: 0-, 3.0 v, 60 μs, 130 Hz
6F167+R legR limbs, trunk20/1L-dopa, TrihexyphenidylR: 4-, 2.9 v, 60 μs, 130 Hz
L: 0-, 2.9 v, 60 μs, 130 Hz
7F634TrunkTrunk, both legs23/3L-dopa, TrihexyphenidylR: 6-, 4.6 v, 90 μs, 130 Hz
L: 2-, 4.6 v, 90 μs, 130 Hz
8F5443R handL limbs24/9NoneR: 4-, 3.7 v, 60 μs, 130 Hz
L: 1-, 3.7 v, 60 μs, 130 Hz
9F3625+L footTrunk, L limbs21/1TrihexyphenidylR: 4-, 4.6 v, 90 μs, 130 Hz
L: 0-, 4.2 v, 90 μs, 130 Hz
10M6243NeckNeck, trunk, L arm28/15Trihexyphenidyl, Baclofen,R: 6 -, 3.7 v, 90 μs, 130 Hz
ClonazepamL: 1-, 3.7 v, 90 μs, 130 Hz
11F2215+L footTrunk, both legs51/11Trihexyphenidyl, BaclofenR: 4-, 3.6v, 60 μs, 130 Hz
L: 0-, 3.6 v, 60 μs, 130 Hz
12F6450R handTrunk, R limbs46/13NoneR: 5,6-, 3.5 v, 60 μs, 130 Hz
L: 1,2-, 3.5 v, 60 μs, 130 Hz
13M627L legNeck, L leg, R arm64/30NoneR: 4,5-, 3.5 v, 60 μs, 130 Hz
L: 1,2-, 3.5 v, 60 μs, 130 Hz
14M4726NeckNeck, R arm25/12NoneR: 4,5-, 3.5 v, 90 μs, 130 Hz
L: 0,1-, 3.5 v, 90 μs, 130 Hz
15F4230+R footR arm, leg27/6NoneR: 5-, 3.5 v, 60 μs, 130 Hz
L: 1-, 3.5 v, 60 μs, 130 Hz
  • BFM, Burke–Fahn–Marsden; DBS, deep brain stimulation.